News for ERYTECH Pharma S.A. (ERYP)

Rising Developments in Newborn Metabolic Screening will propel the Global Market for Phenylketonuria Treatment Market. Increasing Focus on Technological...

ERYTECH Pharma S.A. (NASDAQ:NASDAQ:ERYP) Q3 2022 Earnings Conference Call November 22, 2022, 08:30 AM ET Company Participants Gil Beyen - CEO Eric Soyer - CFO and COO Conference Call...

Read ERYTECH Pharma (NASDAQ:ERYP) Stock Price Down 3.4% at ETF Daily News

The massacre, stock by stock, all 1001 of them, listed right here.

ERYTECH Pharma S.A. (NASDAQ:NASDAQ:ERYP) Q2 2022 Results Conference Call September 13, 2022 08:30 AM ET Company Participants Gil Beyen - Chief Executive Officer Eric Soyer - Chief Financial...

Read Critical Survey: Aerie Pharmaceuticals (NASDAQ:AERI) vs. ERYTECH Pharma (NASDAQ:ERYP) at ETF Daily News

Read Critical Review: Omega Therapeutics (NASDAQ:OMGA) and ERYTECH Pharma (NASDAQ:ERYP) at ETF Daily News

Read Reviewing Gilead Sciences (NASDAQ:GILD) and ERYTECH Pharma (NASDAQ:ERYP) at ETF Daily News

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1% on Thursday.

U.S. stocks traded higher midway through trading, with the Nasdaq Composite adding around 100 points on Thursday.

Toward the end of trading Friday, the Dow traded down 0.42% to 34,936.96 while the NASDAQ fell 0.75% to 14,667.14. The S&P also fell, dropping...

Midway through trading Friday, the Dow traded down 0.25% to 34,996.01 while the NASDAQ fell 0.62% to 14,686.02. The S&P also fell, dropping 0.45% to ...